Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Jones

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
European Journal of Gastroenterology & Hepatology|March 18, 2021
Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitisViraj C Kariyawasam, Fadi H Mourad, Nikola Mitrev, et al.
Health Technology Assessment (Winchester, England)|July 28, 2021
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCTOlivia Wu, Elaine McCartney, Robert Heggie, et al.
Genetics|February 24, 2022
Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targetsNicolas Helmstetter, Aleksandra D Chybowska, Christopher Delaney, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolitesKevin J Hodgetts, Charles A Blum, Timothy Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonistXiaozhang Zheng, Kevin J Hodgetts, Harry Brielmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxinGuy R Seabrook, Kathy G Sutton, Wolfgang Jarolimek, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2024
The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis systemBenjamin Talbot, Simon Davies, Jenny Burman, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
O-arylmandelic acids as highly selective human PPAR alpha/gamma agonistsAlan D Adams, Zao Hu, Derek von Langen, et al.
Journal of Chromatography. A|August 20, 2023
Controlling the surface silanol density in capillary columns and planar silicon via the self-limiting, gas-phase deposition of tris(dimethylamino)methylsilane, and quantification of surface silanols after silanization by low energy ion scatteringBehnam Moeini, Joshua W Pinder, Tahereh G Avval, et al.
Inflammatory Bowel Diseases|July 4, 2014
Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's diseaseViraj C Kariyawasam, Christian P Selinger, Peter H Katelaris, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
European Journal of Gastroenterology & Hepatology|March 18, 2021
Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitisViraj C Kariyawasam, Fadi H Mourad, Nikola Mitrev, et al.
Health Technology Assessment (Winchester, England)|July 28, 2021
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCTOlivia Wu, Elaine McCartney, Robert Heggie, et al.
Genetics|February 24, 2022
Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targetsNicolas Helmstetter, Aleksandra D Chybowska, Christopher Delaney, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolitesKevin J Hodgetts, Charles A Blum, Timothy Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonistXiaozhang Zheng, Kevin J Hodgetts, Harry Brielmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxinGuy R Seabrook, Kathy G Sutton, Wolfgang Jarolimek, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2024
The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis systemBenjamin Talbot, Simon Davies, Jenny Burman, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
O-arylmandelic acids as highly selective human PPAR alpha/gamma agonistsAlan D Adams, Zao Hu, Derek von Langen, et al.
Journal of Chromatography. A|August 20, 2023
Controlling the surface silanol density in capillary columns and planar silicon via the self-limiting, gas-phase deposition of tris(dimethylamino)methylsilane, and quantification of surface silanols after silanization by low energy ion scatteringBehnam Moeini, Joshua W Pinder, Tahereh G Avval, et al.
Inflammatory Bowel Diseases|July 4, 2014
Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's diseaseViraj C Kariyawasam, Christian P Selinger, Peter H Katelaris, et al.
Pageof 18